Empliciti Approved for Multiple Myeloma
MONDAY, Nov. 30, 2015 (HealthDay News) -- Empliciti
(elotuzumab), in combination with two other drugs, has been
approved by the U.S. Food and Drug Administration to treat the
blood cancer multiple myeloma. The drug is only approved for
patients who have already been given one-to-three prior therapies
for the disease.
Health Tip: Get the Facts on Iodine
(HealthDay News) -- If you're dwelling on the subject of getting
enough minerals, then calcium, iron and potassium may be more on
your mind than iodine.